ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Heart transplant patients"

  • 2017 American Transplant Congress

    Post-Transplant Sensitization: Does it Make a Difference in the Development of First-Year Intimal Thickening?

    J. Patel, M. Kittleson, L. Czer, T. Aintablian, E. Stimpson, B. Azarbal, D. Geft, D. Chang, F. Esmailian, J. Kobashigawa.

    Cedars-Sinai Heart Institute, Los Angeles

    Background: The development of donor specific antibody (DSA) after heart transplantation has been reported to be associated with the development of cardiac allograft vasculopathy (CAV).…
  • 2017 American Transplant Congress

    High Titer De Novo Donor-Specific HLA Alloantibodies and Cardiac Allograft Vasculopathy After Pediatric Heart Transplantation.

    B. Das,1 S. Zhang,2 A. Gao,2 C. Lacelle.3

    1Division of Cardiology, Dept. of Pediatrics, UTSW Medical Center, Dallas, TX; 2Department of Clinical Science Research, UTSW Medical Center, Dallas, TX; 3Department of Pathology, UTSW Medical Center, Dallas, TX

    Background: Cardiac allograft vasculopathy (CAV) continues to be a limiting factor in long-term survival after pediatric heart transplantation (HT). Criteria for early diagnosis of CAV…
  • 2017 American Transplant Congress

    Severe Tricuspid Regurgitation After Heart Transplantation: Does It Require Surgical Repair?

    J. Patel, M. Kittleson, L. Czer, T. Aintablian, R. Sharoff, R. Levine, A. Velleca, D. Ramzy, F. Esmailian, J. Kobashigawa.

    Cedars-Sinai Heart Institute, Los Angeles

    Background: Tricuspid regurgitation (TR) after heart transplantation is common. Causes for TR may be due to volume overload, flail tricuspid leaflet from endomyocardial biopsy, pulmonary…
  • 2016 American Transplant Congress

    Management and Outcomes of Upper Extremity Deep Venous Thrombosis in Heart Transplant Patients.

    A. Panakos,1 D. Kramer,1 M. McCarey,1 P. Mather.2

    1Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA; 2Cardiology, Thomas Jefferson University Hospital, Philadelphia, PA.

    Upper extremity deep venous thrombosis (UEDVT) is common in post-heart transplant (OHT) patients, likely due to their multiple intravascular catheters and post-surgical state. The clinical…
  • 2016 American Transplant Congress

    Delaying the Induction of Mixed Chimerism Until Two Months After NHP Heart and Kidney Cotransplantation Results in Long Term Survival.

    K. Huh,1 M. Tonsho,1 P. Spencer,1 J. Paster,1 X. Wu,1 I. Hanekamp,1 T. Kawai,1,3 R. Smith,2 A. Cosimi,1 A. Dehnadi,1 G. Benichou,1 R. Colvin,1,2 J. Madsen.1,4

    1Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA; 2Department of Pathology, Massachusetts General Hospital, Boston, MA; 3Department of Surgery, Massachusetts General Hospital, Boston, MA; 4Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA.

    Background. We have previously achieved delayed tolerance in cynomologous recipients cotransplanted with heart and kidney allografts by treating recipients with standard triple drug immunosuppression for…
  • 2016 American Transplant Congress

    Posterior Reversible Encephalopathy Syndrome After Pediatric Heart Transplantation: Increased Risk for Children with Preexisting Glenn/Fontan Physiology.

    M. Kemna,1 B. Eilers,2 E. Albers,1 Y. Law.1

    1Pediatric Cardiology, Seattle Children's Hospital, Seattle, WA; 2School of Medicine, University of Washington, Seattle, WA.

    Study aim:Identification of risk factors for posterior reversible encephalopathy syndrome (PRES) after organ transplant can improve early detection and avoid permanent neurologic injury. High calcineurin-inhibitor…
  • 2016 American Transplant Congress

    Renal Outcomes of Pediatric Kidney Transplant Recipients Following a Previous Solid Organ Transplantation.

    G. Hamdani,1 B. Zhang,2 J. Goebel,3 E. Nehus.1

    1Division of Nephrology & Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; 2Center for Epidemiology & Biostatistics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; 3Nephrology, Children's Hospital Colorado, Aurora, CO.

    Purpose: We aimed to study the renal outcomes of pediatric kidney transplant recipients following a previous non-renal solid organ transplantation (SOT).Methods: A retrospective analysis of…
  • 2016 American Transplant Congress

    Elucidating Clinical Factors Implicated in Primary Graft Dysfunction After Heart Transplantation.

    R. Quintana-Quezada, I. Rajapreyar, Y. Yeh, S. Choi, I. Gregoric, P. Loyalka, B. Kar.

    Advanced Heart Failure, University of Texas Medical School at Houston, Houston, TX.

    Primary graft dysfunction (PGD) is a frequent complication after heart transplantation (HT) and remains among the leading causes of mortality in these patients. We aim…
  • 2016 American Transplant Congress

    Natural Killer CD16/FcR Profiles May Associate with Enhanced Humoral Responsiveness in Heart Transplant Recipients with Cardiac Allograft Vasculopathy.

    P. Paul,1,2 C. Picard,3,4 E. Sampol,5 L. Lyonnet,1 J. Di Cristofaro,3,4 G. Lano,6, B. Dussol,6, F. Collart,7 F. Sabatier,1,2 F. Dignat George,1,2 A. Mouly Bandini.7

    1Hematology, Assistance Publique-Hopitaux Marseille (AP-HM), Marseille, France; 2UMR-1076, Aix Marseille Université (AMU), INSERM, Marseille, France; 3Établissement Français du Sang, Marseille, France; 4UMR7268, AMU, CNRS, Marseille, France; 5Pharmacokinetics, AP-HM, Marseille, France; 6Center for Clinical Investigation, AP-HM, Marseille, France; 7Cardiac Surgery, AP-HM, Marseille, France.

    Natural Killer cells (NK) are immune effectors of antibody-dependent cellular cytotoxicity (ADCC). Their role in mediating adverse effects of Donor-specific anti-HLA antibodies (DSA) towards cardiac…
  • 2016 American Transplant Congress

    Morbidity and Mortality of Early Post-Operative Acute Kidney Injury in Cardiothoracic Transplant Recipients.

    J. Casale, A. Logan, C. Doligalski.

    Tampa General Hospital, Tampa, FL.

    Purpose: Early acute kidney injury (AKI) in cardiothoracic transplant recipients (CTTR) has not been well described; renal injury defined by the RIFLE criteria has been…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 30
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences